CDP vs RYN
COPT Defense Properties vs Rayonier — AI-powered side-by-side comparison
CDP
COPT Defense Properties
66
Insufficient Data
VS
| Metric | CDP | RYN |
| AI Score |
66
|
64
|
| Price |
$37.15
|
$21.79
|
| P/E Ratio |
25.61×
|
44.44×
|
| ROE |
10.1%
|
21.5%
|
| Revenue Growth YoY |
—
|
—
|
| Gross Margin |
37.6%
|
17.9%
|
| Debt / Equity |
1.75×
|
0.36×
|
| Dividend Yield |
3.4%
|
11.3%
|
| RSI (14) |
38.9
|
52.1
|
| Beta |
0.786
|
0.907
|
| Expected Upside |
—
|
+1.9%
|
AI Committee View
Current Innellis committee reasoning for CDP versus RYN.
CDP leads by 2 points.
CDP scores 66/100 (Insufficient Data) versus RYN at 64/100 (Buy).
CDP Committee View
100% agreement
3 analysts
The primary driver is market regime is bullish (bull market -- normal position sizing). The main limiting factor is 4 existing position pair(s) are highly correlated already. The committee is constructive but not yet at full conviction.
Bull Case
- Price structure making higher highs and higher lows — Technical
- Trend and market structure agree -- coherent bullish picture — Technical
- Weekly trend (uptrend) confirms the daily trend -- multi-timeframe agreement — Technical
Bear Case
- MACD histogram negative -- bearish momentum — Technical
RYN Committee View
80% agreement
5 analysts
The primary driver is p/e of 14.2 is inexpensive for the broad market. The main limiting factor is macd histogram negative -- bearish momentum. The committee is constructive but not yet at full conviction.
Bull Case
- P/E of 14.2 is inexpensive for the broad market — Value
- ROE of 15.4% shows genuine earnings power backing the valuation — Value
- Dividend yield of 4.9% pays you to wait — Value
Bear Case
- Revenue declining -42.4% YoY -- this is not a growth story right now — Growth
- MACD histogram negative -- bearish momentum — Technical